Skip to content

BMED vs PSR

iShares Health Innovation Active ETF

BMEDBNYSE Arca

Invesco Active U.S. Real Estate ETF

PSRANYSE Arca

Overlap

Expense ratio

PSR −0.20pt a year

BMED0.55%PSR0.35%

Avg volume · 30D

BMED 1.5×the volume

BMED2.15KPSR1.45K

5Y return · a year

BMED +3.2pt

BMED+4.2%PSR+1.0%

BMED vs PSR Performance

Oct 29, 2021 – Oct 30, 2026

+23.0%BMED+5.1%PSR

Oct 29, 2021 to Oct 30, 2026. BMED +23.0%. PSR +5.1%. Use the arrow keys to read each point.−30%−20%−10%Oct 2021Apr 2024Oct 2026
Expense ratio
BMED 0.55%
PSR 0.35%, better
Fund size
BMED $15M
PSR $57M
1Y total return
BMED +28.3%, better
PSR +13.9%
Yield (12M)
BMED 0.22%
PSR 2.70%, better
Holdings
BMED 61
PSR 37
Avg volume (30D)
BMED 2.15K sh, better
PSR 1.45K sh
NAV per share
BMED $36.46
PSR $100.85
52W range

ETF.net Grade

BMED: Cost 72, Risk 61, Mission 77, Tradability 31, Holdings 74, Durability 60. PSR: Cost 85, Risk 56, Mission not scored, Tradability 58, Holdings 66, Durability 75.
Pillar letters and Scores for BMED, PSR, with each pillar’s weight
PillarBMEDPSR
Cost30% weightA72A85Higher
Mission25% weightA77Not scored
Risk15% weightB61HigherB56
Tradability15% weightD31B58Higher
Holdings10% weightA74HigherB66
Durability5% weightB60A75Higher

Rank among US Active Sector funds

Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. BMED and PSR are both graded against the same 35 US Active Sector funds, so their Grades compare head to head.

US Active Sector⁠

Category · 35 funds
See all 35 ›

PSR ranks 2nd and BMED 7th of 35 funds in the US Active Sector Category.

  1. Rank 1AAVREAvantis Real Estate ETFScore 77
  2. Rank 2APSRInvesco Active U.S. Real Estate ETFScore 70
  3. Rank 2BTMEDT. Rowe Price Health Care ETFScore 70
  4. Rank 6BTRUCVanEck Communication Services TruSector ETFScore 64
  5. Rank 7BBMEDiShares Health Innovation Active ETFScore 61
  6. Rank 7BLFSCF/M Emerald Life Sciences Innovation ETFScore 61

Our read on each fund

ETF.net Research

BMEDBiShares Health Innovation Active ETF

PSRAInvesco Active U.S. Real Estate ETF

In short

BMED Most health ETFs are a shelf of mega-cap pharma. BMED's stock pickers hunt the other end: roughly 60 innovative and emerging health names tilted to mid and small caps worldwide, 0.55% net of a waiver through June 30, 2027.

PSR Active REIT stock-picking without the active price tag: since 2008, PSR has run a tight book of about 30 US property names for 0.35% a year, roughly half the median fee among active US equity ETFs.

Stated mandate

BMED The Fund seeks to maximize total return through active investment in innovative and emerging healthcare companies.

PSR The Fund seeks high total return through capital appreciation and current income, investing principally in equity real estate investment trusts.

Why people hold it

  • BMED Mandate is specific: at least 80% of net assets in health sciences stocks, with the focus on mid- and small-cap innovators anywhere in the world, emerging markets included.sec.gov
  • 0.55% net of a waiver through June 30, 2027 (0.77% gross), below the median fee among the 35 active sector funds in its group.
  • Reach goes past drugmakers: devices, diagnostics, REITs that own hospitals, even animal and plant health sit inside the prospectus definition.sec.gov
  • About 60 names means each pick carries weight, and the portfolio matches the innovation mandate it advertises, one of the stronger builds in its active sector peer group.
  • PSR 0.35% a year against a 0.65% median for active US equity ETFs. Active management without the usual active-management markup.
  • Running since 2008, across multiple rate regimes and property cycles, and it sits in the upper half of its active US equity peer group.
  • Concentrated by design: about 30 equity REITs, so each holding carries real weight instead of being diluted across the entire property market.invesco.com
  • The mandate targets capital appreciation plus current income from equity REITs, and the fund distributes quarterly.invesco.com

Worth knowing

  • BMED Small fund, light trading. Spreads can widen and the market price can drift from net asset value, which bites hardest on bigger orders.sec.gov
  • Mid caps, small caps and emerging-market names in a book of about 60 stocks move harder in both directions than mega-cap pharma.sec.gov
  • That 0.55% leans on a waiver running to June 30, 2027; gross is 0.77%. Active healthcare peer TMED charges 0.44% with no waiver attached.
  • PSR Thinly traded. Spreads can widen and larger orders can move the price more than they would in a heavily traded index fund.
  • One sector, one economy: US property. When rates jolt REITs, the portfolio has no other sector to lean on.
  • Assets stay modest next to the giant index REIT funds, and smaller ETFs generally face a higher bar to stay open over the long haul.

Full BMED profile⁠

Full PSR profile⁠

BMED vs PSR Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

BMED vs PSR Cost

Overpaying BMED vs PSR

$3,778

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • BMED 0.55%

    $10,904

  • PSR 0.35%

    $7,126

$10,000
30 years

Cost over time

  • BMED 0.55%
  • PSR 0.35%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2.5K$5K$7.5K$10K$12.5K051015202530BMED $10,904PSR $7,126

Year by year

YearBMEDPSROverpaying
10$988$634$354
20$3,790$2,454$1,336
30$10,904$7,126$3,778

Expense ratio

  • 0.55%BMED
  • 0.35%PSR, cheaper
  • Middle half of US Active Sector funds
  • Median 0.61%

PSR 6th cheapest of 35 funds

BMED 10th cheapest of 35 funds

BMED vs PSR Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
BMED 0.22%
PSR 2.70%, better
Payout (12M)
BMED $0.08
PSR $2.72
Last payment
BMED $0.08
PSR $0.67
Ex-dividend
BMED Jun 15, 2026
PSR Sep 21, 2026
Paid on
BMED Jun 18, 2026
PSR Sep 25, 2026
Frequency
BMED Irregular
PSR Quarterly

Distribution history

Per share, 2017 to 2026, same scale for both

BMEDIrregular · 2 paymentsAll BMED payments⁠
One bar per payment. 2 payments from 2017 to 2026 YTD. Dec 20, 2023 $0.0072; Jun 15, 2026 $0.08. Use the arrow keys to read each point.$0$0.502017202020232026YTD
PSRQuarterly · 36 paymentsAll PSR payments⁠
One bar per payment. 36 payments from 2017 to 2026 YTD. Dec 18, 2017 $0.11; Mar 19, 2018 $0.30; Jun 18, 2018 $0.44; Sep 24, 2018 $0.57; Dec 24, 2018 $0.70; Mar 18, 2019 $0.16; Jun 24, 2019 $0.75; Sep 23, 2019 $0.76; Dec 23, 2019 $0.76; Mar 23, 2020 $0.70; Jun 22, 2020 $0.64; Sep 21, 2020 $0.64; Dec 21, 2020 $0.70; Mar 22, 2021 $0.60; Jun 21, 2021 $0.69; Sep 20, 2021 $0.61; Dec 20, 2021 $0.65; Mar 21, 2022 $0.63; Jun 21, 2022 $0.68; Sep 19, 2022 $0.63; Dec 19, 2022 $0.63; Mar 20, 2023 $0.65; Jun 20, 2023 $0.65; Sep 18, 2023 $0.69; Dec 18, 2023 $0.69; Mar 18, 2024 $0.69; Jun 24, 2024 $0.70; Sep 23, 2024 $0.69; Dec 23, 2024 $0.69; Mar 24, 2025 $0.56; Jun 23, 2025 $0.58; Sep 22, 2025 $0.59; Dec 22, 2025 $0.59; Mar 23, 2026 $0.67; Jun 22, 2026 $0.78; Sep 21, 2026 $0.67. Use the arrow keys to read each point.$0$0.502017202020232026YTD

BMED vs PSR Risk

Fall from peak · 5 years

  • BMED
  • PSR
Oct 29, 2021 to Oct 30, 2026. Worst fall: BMED −32.1% · Sep 2022. Use the arrow keys to read each point.−30%−20%−10%0%Oct 2021Apr 2024Oct 2026

Risk facts

VolatilityStd dev, 3 years
BMED 15.3%, betterPSR 16.5%
Return per unit of riskSharpe ratio, 3 years
BMED 1.03, betterPSR 0.54
Worst fallMax drawdown, 5 years
BMED −32.1%, betterPSR −34.8%
Market sensitivityBeta, 5 years
BMED 0.74PSR 0.95

Popular comparisons

  • BMEDBvsAVREA

    iShares Health Innovation Active ETF · Avantis Real Estate ETF

    Expense ratio
    0.55% · 0.17%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • PSRAvsAVREA

    Invesco Active U.S. Real Estate ETF · Avantis Real Estate ETF

    Expense ratio
    0.35% · 0.17%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • BMEDBvsTMEDB

    iShares Health Innovation Active ETF · T. Rowe Price Health Care ETF

    Expense ratio
    0.55% · 0.44%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • PSRAvsTMEDB

    Invesco Active U.S. Real Estate ETF · T. Rowe Price Health Care ETF

    Expense ratio
    0.35% · 0.44%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • BMEDBvsTRUTA

    iShares Health Innovation Active ETF · VanEck Technology TruSector ETF

    Expense ratio
    0.55% · 0.14%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • PSRAvsTRUTA

    Invesco Active U.S. Real Estate ETF · VanEck Technology TruSector ETF

    Expense ratio
    0.35% · 0.14%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.